Home Biosimilar Antibodies Metabolism Others Farletuzumab-MMAE For research use only.
Not for use in humans.

Farletuzumab-MMAE

Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

Farletuzumab-MMAE

CAS No.

Click to purchase products related to Farletuzumab-MMAE

Purity & Quality Control

Batch: D401501 Purity: 99% Protein concentration: 5.59mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

Product Details

ADC antiody Farletuzumab
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Farletuzumab-MMAE | Farletuzumab-MMAE supplier | purchase Farletuzumab-MMAE | Farletuzumab-MMAE cost | Farletuzumab-MMAE manufacturer | order Farletuzumab-MMAE | Farletuzumab-MMAE distributor